How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?

European Journal of Clinical Pharmacology

Volumn 63, Issue 12, 2007, Pages 1171-1177

  Teichert, Martina ^a   Van Der Aalst, Angelie ^b   De Wit, Hans ^c   Stroo, Marcel ^b   De Smet, Peter A G M ^a  

^a Scientific Institute Dutch Pharmacists   (Netherlands)

^b Dutch Institute for Proper Use of Medicines   (Netherlands)

^c Foundation for Pharmaceutical Statistics   (Netherlands)

Author keywords

Drug use 90 method; Pharmacotherapy audit meetings; Prescribing indicators

Indexed keywords

ACARBOSE; AMITRIPTYLINE; ANTACID AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM ANTIBIOTIC; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; FLUVOXAMINE; FUSIDIC ACID; GLUCOCORTICOID; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPRAMINE; INDICATOR; LINCOSAMIDE; MACROLIDE; METFORMIN; NORTRIPTYLINE; PAROXETINE; PRAVASTATIN; SERTRALINE; SIMVASTATIN; STREPTOGRAMIN; SULFONAMIDE; TEMAZEPAM; TETRACYCLINE; TRIMETHOPRIM; UREA DERIVATIVE; ZOLPIDEM;

ARTICLE; COST CONTROL; DATA BASE; DRUG CLASSIFICATION; DRUG INDUSTRY; DRUG QUALITY; GENERAL PRACTITIONER; MULTIVARIATE ANALYSIS; PHARMACOTHERAPY AUDIT MEETING; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; UNIVARIATE ANALYSIS;

CONGRESSES AS TOPIC; CROSS-SECTIONAL STUDIES; DRUG THERAPY; DRUG UTILIZATION REVIEW; FAMILY PRACTICE; HUMANS; NETHERLANDS; PHARMACIES; PHYSICIAN'S PRACTICE PATTERNS; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES;

EID: 36148939078     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0362-9     Document Type: Article

References (23)

1. Muijrers PEM, Grol RPT, Sijbrandij J, Janknegt R, Knottnerus JA (2005) Differences in prescribing between general practitioners. Impact of the cooperation with pharmacists and visits from Pharmaceutical industry representatives. Fam Pract 22(6):624-630
2. Florentinus SR, van Hulten R, Kloth ME, Heerdink ER, Griens AM, Leufkens HG, Groenewegen PP (2007) The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners. Ann Pharmacother 41(2):319-324
3. Muijrers PEM, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RPTM (2004) Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners. Eur J Clin Pharm 60(10):739-746
4. Groot de J, Eimers M (2004) FTO-peiling 2004. Kwaliteit van farmacotherapeutisch overleg in Nederland in beeld. DGV
5. Eimers M, Groot de J, Meulepas M (2006) Benchmark voorschrijven 2006. De ontwikkeling en toepassing van prestatie-indicatoren. DGV
6. Wettermark B, Pehrsson A, Jinnerot D, Bergman U (2003) Drug utilisation 90% profiles-a useful tool for quality asse ssment of prescribing in primary health care in Stockholm. Pharmacoepidemiol Drug Saf 12:499-510
7. Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H, Sjöqvist F (1998) Drug utilization 90%-a simple method or assessing the quality of drug prescribing. Eur J Clin Pharmacol 54:113-118
8. Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J (2004) Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002. JAMA 7:291(1):54-62 (Jan)
9. Hoven JL, Haaijer_Ruskamp FM, Van der STichele RH (2005) Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004). Eur J Clin Pharmacol 60(11):831-834
10. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT (2002) PREVEND study group prevention of renal and vascular ENT stage disease. pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 11(5):379-384 (Jul-Aug)
11. World Health Organization Collaborating Centre for Drug Statistics Methodology (2004) Guidelines for ATC Classification and DDD Assignment. Oslo
12. Meulenberg F, Thomas S, van der Voort H (eds) (1993) NHG standards. 5. Examples of guidelines for general practice. Dutch College of General Practitioners, Utrecht, Netherlands
13. Nederlandse Huisartsen Genootschap (1999) NHG Standaard Cholesterol, Huisarts en Wetenschap 42(9)
14. Nederlandse Huisartsen Genootschap (2003) NHG Standaard Maagklachten http://nhg.artsennet.nl, visited 11.02.06
15. Nederlandse Huisartsen Genootschap (2003) NHG Standaard Depressieve Stoornis http://nhg.artsennet.nl, visited 11.02.06
16. Nederlandse Huisartsen Genootschap (1992) NHG Standaard Slaapproblemen en slaapmiddelen. http://nhg.artsennet.nl, visited 11.02.06
17. Nederlandse Huisartsen Genootschap (1998). NHG Standaard Astma bij kinderen. http://nhg.artsennet.nl, visited 11.02.06
18. Nederlandse Huisartsen Genootschap (2001) NHG Standaard Astma bij volwassenen. http://nhg.artsennet.nl, visited 11.02.06
19. Nederlandse Huisartsen Genootschap (1999) NHG Standaard Diabetes mellitus type 2. Huisarts en Wetenschap 42:67-84
20. Bosmans JE, Brook OH, van Hout HP, de Bruijne MC, Nieuwenhuyse H, Bouter LM, Stalman WA, van Tulder MW (2007) Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants. Pharmacoeconomics 25(1):25-37
21. Rosenberg JM, Zerilli T, Nathan JP, McGuire H (2007) Use of statins and gemfibrozil in patients with type 2 diabetes mellitus and cardiovascular risk factors attending adult day health care centers: an opportunity for pharmacists. Consult Pharm 22(1):38-44
22. Abdullah AK, Khan S (2007) Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma. J Asthma 44(1):1-12
23. College voor Zorgverzekeringen CVZ (2004) Farmacotherapeutisch Kompas.CVZ, Naarden 2004